2009-11-25 12:39:42 - Pulmonary Drug Delivery Technologies - A Global Market Perspective - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Market-Report/pulmonary-drug ..

""Until recent years, respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease represented the sole therapeutic areas of the pulmonary sector. However, recent technological advancements have spanned the application of pulmonary devices to the treatment of non-respiratory conditions such diabetes, migraine. The attractiveness of pulmonary delivery of drugs for the treatment of respiratory diseases stems from the fact that topical drug deposition to infected lung gives a fast therapeutic effect and reduces side effects associated with key drugs.

Advancements in formulating technology are expected to push sales of dry powder inhalers replacing metered-dose inhalers to a larger extent. Dry powder inhalation (DPI), an enabling concept in the noninvasive drug delivery, is progressively emerging as important contender among pulmonary

 

 

drug delivery methods. This importance is being fueled by latest developments including sophisticated device architectures, growing research activity in powder formulations, and innovations in particle engineering.

These and other market data and trends are presented in """"Pulmonary Drug Delivery Technologies: A Global Market Perspective"""" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.""